127 related articles for article (PubMed ID: 32498759)
1. Continuous Stakeholder Engagement: Expanding the Role of Pharmacists in Prevention of Type 2 Diabetes Through the National Diabetes Prevention Program.
Ross LW; Bana F; Blacher RJ; McDivitt J; Petty J; Beckner J; Montierth R
Prev Chronic Dis; 2020 Jun; 17():E41. PubMed ID: 32498759
[TBL] [Abstract][Full Text] [Related]
2. The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders.
Katangwe T; Family H; Sokhi J; Al-Jabr H; Kirkdale CL; Twigg MJ
PLoS One; 2019; 14(7):e0219686. PubMed ID: 31318897
[TBL] [Abstract][Full Text] [Related]
3. Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery.
Spence R; Sisson EM; Dixon DL
J Am Pharm Assoc (2003); 2022; 62(5):1581-1586. PubMed ID: 35461779
[TBL] [Abstract][Full Text] [Related]
4. Facilitators to referrals to CDC's National Diabetes Prevention Program in primary care practices and pharmacies: DocStyles 2016-2017.
Nhim K; Khan T; Gruss S; Wozniak G; Kirley K; Schumacher P; Albright A
Prev Med; 2021 Aug; 149():106614. PubMed ID: 33989676
[TBL] [Abstract][Full Text] [Related]
5. Using a RE-AIM framework to identify promising practices in National Diabetes Prevention Program implementation.
Nhim K; Gruss SM; Porterfield DS; Jacobs S; Elkins W; Luman ET; Van Aacken S; Schumacher P; Albright A
Implement Sci; 2019 Aug; 14(1):81. PubMed ID: 31412894
[TBL] [Abstract][Full Text] [Related]
6. Stakeholders' perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers.
Rodrigues AM; Haste A; Penn L; Bell R; Summerbell C; White M; Adamson AJ; Sniehotta FF
BMC Health Serv Res; 2020 Apr; 20(1):307. PubMed ID: 32293424
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
8. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
Drake ES; Harris DK; Marciniak MW
J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
[TBL] [Abstract][Full Text] [Related]
9. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP).
Mathews E; Thomas E; Absetz P; D'Esposito F; Aziz Z; Balachandran S; Daivadanam M; Thankappan KR; Oldenburg B
BMC Public Health; 2018 Jan; 17(1):974. PubMed ID: 29298703
[TBL] [Abstract][Full Text] [Related]
10. Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives.
Roszak SE; Ferreri SP
Prev Chronic Dis; 2020 Aug; 17():E90. PubMed ID: 32816661
[TBL] [Abstract][Full Text] [Related]
11. Qualitative Assessment of a State Partner-Facilitated Health Care-Associated Infection Prevention National Collaborative.
Fowler KE; Forman J; Ameling JM; Rolle AJ; Bohr D; Schwartz B; Collier S; Chopra V; Meddings J
Ann Intern Med; 2019 Oct; 171(7_Suppl):S75-S80. PubMed ID: 31569227
[TBL] [Abstract][Full Text] [Related]
12. Implementation strategies from deployment of the National Diabetes Prevention Program in Pennsylvania community pharmacies.
Lapping AD; Carroll JC; Coley KC; Somma McGivney MA; Doong K; Antinopoulos B; Richardson R; Berenbrok LA
J Am Pharm Assoc (2003); 2020; 60(3S):S29-S36.e1. PubMed ID: 32122758
[TBL] [Abstract][Full Text] [Related]
13. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
[TBL] [Abstract][Full Text] [Related]
14. A systematic review exploring characteristics of lifestyle modification interventions in newly diagnosed type 2 diabetes for delivery in community pharmacy.
Katangwe T; Bhattacharya D; Twigg MJ
Int J Pharm Pract; 2019 Feb; 27(1):3-16. PubMed ID: 30697864
[TBL] [Abstract][Full Text] [Related]
15. A pharmacy-based referral program to assist low-income Medicare beneficiaries.
Hastings TJ; Hohmann LA; Neal J; Westrick SC
J Am Pharm Assoc (2003); 2019; 59(3):416-422. PubMed ID: 30826302
[TBL] [Abstract][Full Text] [Related]
16. Implementation of technician-driven medication therapy management program in community pharmacies.
Burnside TPT; Scott NJ; Smith MG
J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
18. National survey of pharmacy-based immunization services.
Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
[TBL] [Abstract][Full Text] [Related]
19. What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes.
Lee EL; Wong PS; Tan MY; Sheridan J
Int J Pharm Pract; 2018 Apr; 26(2):138-147. PubMed ID: 28574154
[TBL] [Abstract][Full Text] [Related]
20. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.
Ely EK; Gruss SM; Luman ET; Gregg EW; Ali MK; Nhim K; Rolka DB; Albright AL
Diabetes Care; 2017 Oct; 40(10):1331-1341. PubMed ID: 28500215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
